Transcription of 審議結果報告書 - pmda.go.jp
{{id}} {{{paragraph}}}
Example: marketing
審議結果報告書 - pmda.go.jp
27 50mg 26 19 27 28 10 1 27 5 19 50mg 26 9 19 1 10mL 50mg 1 T -4 IgG1 448 H 1 2 215 L 2 148,000 Ipilimumab is a recombinant human IgG1 monoclonal antibody against human cytotoxic T-lymphocyte-associated antigen 4.
審議結果報告書 平成27年6月3日 医薬食品局審査管理課 [販売名] ヤーボイ点滴静注液50mg [一般名] イピリムマブ（遺伝子組換え）
Loading..
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: